Allergan

Britain’s Shire Plc recently rejected Allergan’s takeover approach: report

25 Apr 2014

Shire, the UK's third-biggest drug maker with a market cap of $33 billion, is itself an aggressive acquirer, having made 15 acquisitions since 2000

Valeant tables hostile $45.7 bn bid for Botox maker Allergan

23 Apr 2014

Valeant Pharmaceuticals International Inc, Canada's biggest drug maker and one of the most aggressive acquirers, yesterday tabled a hostile $45.7-billion cash and stock bid for Botox maker Allergan Inc

Valeant teams up with hedge fund to buy Botox maker Allergan for $42 bn

22 Apr 2014

News of the impending bid sent the stock price of Valeant and Allergan companies soaring in after-hours trading

Allergan to buy SkinMedica’s skin care unit for $350 million

19 Nov 2012

Allergan explores sale of obesity intervention business

31 Oct 2012

Allergan to buy more eye-care brands

By Ananth Iyer | 22 Apr 1999